Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1

Molecular and Cellular Biology

Volumn 30, Issue 21, 2010, Pages 5194-5206

  Moussa, Omar ^a   LaRue, Amanda C ^a,b   Abangan Jr , Romeo S ^a,b   Williams, Christopher R ^a,b   Zhang, Xian K ^a   Masuya, Masahiro ^b   Gong, Yong Z ^a   Spyropoulos, Demetri D ^a   Ogawa, Makio ^a,b   Gilkeson, Gary ^a,b   Watson, Dennis K ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FLI 1; TRANSCRIPTION FACTOR GATA 1; FLI1 PROTEIN, MOUSE; GATA1 PROTEIN, MOUSE; MUTANT PROTEIN; PEPTIDE FRAGMENT; PRIMER DNA;

ADULTHOOD; ANIMAL CELL; ARTICLE; BONE MARROW; CARBOXY TERMINAL SEQUENCE; DOWN REGULATION; EMBRYO; GENE EXPRESSION; HETEROZYGOSITY; HOMOZYGOSITY; LETHALITY; MEGAKARYOCYTE; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; ANIMAL; BLOOD; C57BL MOUSE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DEFICIENCY; FEMALE; GENETIC TRANSFECTION; GENETICS; HELA CELL LINE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; MUTANT MOUSE STRAIN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PREGNANCY; PROTEIN TERTIARY STRUCTURE; THROMBOCYTE ACTIVATION; TRANSGENIC MOUSE;

MUS;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; DNA PRIMERS; FEMALE; GATA1 TRANSCRIPTION FACTOR; HELA CELLS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MEGAKARYOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MUTANT PROTEINS; PEPTIDE FRAGMENTS; PLATELET ACTIVATION; PLATELET COUNT; PREGNANCY; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEIN C-FLI-1; THROMBOCYTOPENIA; TRANSFECTION;

EID: 77957856698     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01112-09     Document Type: Article

References (71)

1. Arvand, A., S. M. Welford, M. A. Teitell, and C. T. Denny. 2001. The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1. Cancer Res. 61:5311-5317.
2. Asano, Y., M. Markiewicz, M. Kubo, G. Szalai, D. K. Watson, and M. Trojanowska. 2009. Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin. Mol. Cell. Biol. 29:425-434.
3. Athanasiou, M., P. A. Clausen, G. J. Mavrothalassitis, X. K. Zhang, D. K. Watson, and D. G. Blair. 1996. Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype. Cell Growth Differ. 7:1525-1534.
4. Ben-David, Y., E. B. Giddens, K. Letwin, and A. Bernstein. 1991. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 5:908-918.
5. Bergeron, D., B. Barbeau, C. Leger, and E. Rassart. 1995. Experimental bias in the evaluation of the cellular transient expression in DNA co-transfection experiments. Cell Mol. Biol. Res. 41:155-159.
6. Bergeron, D., J. Houde, L. Poliquin, B. Barbeau, and E. Rassart. 1993. Expression and DNA rearrangement of proto-oncogenes in Cas-Br-E-induced non-T-, non-B-cell leukemias. Leukemia 7:954-962. (Pubitemid 23230973)
7. Bouillet, P., D. Metcalf, D. C. Huang, D. M. Tarlinton, T. W. Kay, F. Kontgen, J. M. Adams, and A. Strasser. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735-1738.
8. Boyd, K. E., and P. J. Farnham. 1999. Identification of target genes of oncogenic transcription factors. Proc. Soc. Exp. Biol. Med. 222:9-28.
9. Carrell, N. A., L. A. Fitzgerald, B. Steiner, H. P. Erickson, and D. R. Phillips. 1985. Structure of human platelet membrane glycoproteins IIb and IIIa as determined by electron microscopy. J. Biol. Chem. 260:1743-1749.
10. Dalgleish, P., and A. D. Sharrocks. 2000. The mechanism of complex formation between Fli-1 and SRF transcription factors. Nucleic Acids Res. 28:560-569.
11. Darby, T. G., J. D. Meissner, A. Ruhlmann, W. H. Mueller, and R. J. Scheibe. 1997. Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1. Oncogene 15:3067-3082.
12. Denicourt, C., E. Edouard, and E. Rassart. 1999. Oncogene activation in myeloid leukemias by Graffi murine leukemia virus proviral integration. J. Virol. 73:4439-4442. (Pubitemid 29189891)
13. Deveaux, S., A. Filipe, V. Lemarchandel, J. Ghysdael, P. H. Romeo, and V. Mignotte. 1996. Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood 87:4678-4685.
14. Eisbacher, M., M. L. Holmes, A. Newton, P. J. Hogg, L. M. Khachigian, M. Crossley, and B. H. Chong. 2003. Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding. Mol. Cell. Biol. 23:3427-3441.
15. Fitzsimmons, D., W. Hodsdon, W. Wheat, S. M. Maira, B. Wasylyk, and J. Hagman. 1996. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10:2198-2211.
16. Fitzsimmons, D., R. Lutz, W. Wheat, H. M. Chamberlin, and J. Hagman. 2001. Highly conserved amino acids in Pax and Ets proteins are required for DNA binding and ternary complex assembly. Nucleic Acids Res. 29:4154-4165. (Pubitemid 33019559)
17. Fujiwara, Y., C. P. Browne, K. Cunniff, S. C. Goff, and S. H. Orkin. 1996. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. U. S. A. 93: 12355-12358.
18. Hart, A., F. Melet, P. Grossfeld, K. Chien, C. Jones, A. Tunnacliffe, R. Favier, and A. Bernstein. 2000. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 13:167-177.
19. Holmes, M. L., N. Bartle, M. Eisbacher, and B. H. Chong. 2002. Cloning and analysis of the thrombopoietin-induced megakaryocyte-specific glycoprotein VI promoter and its regulation by GATA-1, Fli-1, and Sp1. J. Biol. Chem. 277:48333-48341.
20. Hsu, T., M. Trojanowska, and D. K. Watson. 2004. Ets proteins in biological control and cancer. J. Cell Biochem. 91:896-903.
21. Huang, H., M. Yu, T. E. Akie, T. B. Moran, A. J. Woo, N. Tu, Z. Waldon, Y. Y. Lin, H. Steen, and A. B. Cantor. 2009. Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. Mol. Cell. Biol. 29:4103-4115.
22. Ichikawa, M., T. Asai, T. Saito, S. Seo, I. Yamazaki, T. Yamagata, K. Mitani, S. Chiba, S. Ogawa, M. Kurokawa, and H. Hirai. 2004. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10:299-304.
23. Jackers, P., G. Szalai, O. Moussa, and D. K. Watson. 2004. Ets-dependent regulation of target gene expression during megakaryopoiesis. J. Biol. Chem. 279:52183-52190.
24. Jackson, C. W. 1973. Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood 42:413-421.
25. Kawada, H., T. Ito, P. N. Pharr, D. D. Spyropoulos, D. K. Watson, and M. Ogawa. 2001. Defective megakaryopoiesis and abnormal erythroid development in Fli-1 gene-targeted mice. Int. J. Hematol. 73:463-468.
26. Kruse, E. A., S. J. Loughran, T. M. Baldwin, E. C. Josefsson, S. Ellis, D. K. Watson, P. Nurden, D. Metcalf, D. J. Hilton, W. S. Alexander, and B. T. Kile. 2009. Dual requirement for the ETS transcription factors Fli-1 and Erg in hematopoietic stem cells and the megakaryocyte lineage. Proc. Natl. Acad. Sci. U. S. A. 106:13814-13819.
27. Kwiatkowski, B. A., A. G. Zielinska-Kwiatkowska, T. R. Bauer, Jr., and D. D. Hickstein. 2000. The ETS family member Tel antagonizes the Fli-1 phenotype in hematopoietic cells. Blood Cells Mol. Dis. 26:84-90.
28. Lecine, P., J. L. Villeval, P. Vyas, B. Swencki, Y. Xu, and R. A. Shivdasani. 1998. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood 92:1608-1616.
29. Lemarchandel, V., J. Ghysdael, V. Mignotte, C. Rahuel, and P. H. Romeo. 1993. GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol. Cell. Biol. 13:668-676.
30. Leon, C., B. Hechler, M. Freund, A. Eckly, C. Vial, P. Ohlmann, A. Dierich, M. LeMeur, J. P. Cazenave, and C. Gachet. 1999. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. J. Clin. Invest. 104:1731-1737.
31. Levene, R. B., J. M. Lamaziere, H. E. Broxmeyer, L. Lu, and E. M. Rabellino. 1985. Human megakaryocytes. V. Changes in the phenotypic profile of differentiating megakaryocytes. J. Exp. Med. 161:457-474.
32. Levin, J., J. P. Peng, G. R. Baker, J. L. Villeval, P. Lecine, S. A. Burstein, and R. A. Shivdasani. 1999. Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2. Blood 94:3037-3047.
33. Loughran, S. J., E. A. Kruse, D. F. Hacking, C. A. de Graaf, C. D. Hyland, T. A. Willson, K. J. Henley, S. Ellis, A. K. Voss, D. Metcalf, D. J. Hilton, W. S. Alexander, and B. T. Kile. 2008. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat. Immunol. 9:810-819.
34. Maier, H., R. Ostraat, S. Parenti, D. Fitzsimmons, L. J. Abraham, C. W. Garvie, and J. Hagman. 2003. Requirements for selective recruitment of Ets proteins and activation of mb-1/Ig-alpha gene transcription by Pax-5 (BSAP). Nucleic Acids Res. 31:5483-5489.
35. Mao, X., S. Miesfeldt, H. Yang, J. M. Leiden, and C. B. Thompson. 1994. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J. Biol. Chem. 269:18216-18222.
36. Masuya, M., O. Moussa, T. Abe, T. Deguchi, T. Higuchi, Y. Ebihara, D. D. Spyropoulos, D. K. Watson, and M. Ogawa. 2005. Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice. Blood 105:95-102. (Pubitemid 40053069)
37. Mathur, A., Y. Hong, G. Wang, and J. D. Erusalimsky. 2004. Assays of megakaryocyte development: surface antigen expression, ploidy, and size. Methods Mol. Biol. 272:309-322.
38. Mignotte, V., I. Vigon, E. Boucher de Crevecoeur, P. H. Romeo, V. Lemarchandel, and S. Chretien. 1994. Structure and transcription of the human c-mpl gene (MPL). Genomics 20:5-12.
39. Niitsu, N., Y. Yamamoto-Yamaguchi, H. Miyoshi, K. Shimizu, M. Ohki, M. Umeda, and Y. Honma. 1997. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells. Cell Growth Differ. 8:319-326.
40. Oettgen, P., E. Finger, Z. Sun, Y. Akbarali, U. Thamrongsak, J. Boltax, F. Grall, A. Dube, A. Weiss, L. Brown, G. Quinn, K. Kas, G. Endress, C. Kunsch, and T. A. Libermann. 2000. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J. Biol. Chem. 275:1216-1225.
41. Ohno, T., V. N. Rao, and E. S. Reddy. 1993. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res. 53:5859-5863.
42. Ott, D. E., J. Keller, and A. Rein. 1994. 10A1 MuLV induces a murine leukemia that expresses hematopoietic stem cell markers by a mechanism that includes fli-1 integration. Virology 205:563-568.
43. Pang, L., H. H. Xue, G. Szalai, X. Wang, Y. Wang, D. K. Watson, W. J. Leonard, G. A. Blobel, and M. Poncz. 2006. Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins. Blood 108:2198-2206.
44. Phillips, D. R., I. F. Charo, L. V. Parise, and L. A. Fitzgerald. 1988. The platelet membrane glycoprotein IIb-IIIa complex. Blood 71:831-843.
45. Putz, G., A. Rosner, I. Nuesslein, N. Schmitz, and F. Buchholz. 2006. AML1 deletion in adult mice causes splenomegaly and lymphomas. Oncogene 25: 929-939. (Pubitemid 43237711)
46. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878-4884.
47. Rabellino, E. M., R. B. Levene, L. L. Leung, and R. L. Nachman. 1981. Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes. J. Exp. Med. 154:88-100.
48. Ramakers, C., J. M. Ruijter, R. H. Deprez, and A. F. Moorman. 2003. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 339:62-66.
49. Rao, V. N., T. Ohno, D. D. Prasad, G. Bhattacharya, and E. S. Reddy. 1993. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein. Oncogene 8:2167-2173.
50. Raslova, H., E. Komura, J. P. Le Couedic, F. Larbret, N. Debili, J. Feunteun, O. Danos, O. Albagli, W. Vainchenker, and R. Favier. 2004. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/ Jacobsen thrombopenia. J. Clin. Invest. 114:77-84.
51. Schulze, H., and R. A. Shivdasani. 2005. Mechanisms of thrombopoiesis. J. Thromb. Haemost. 3:1717-1724.
52. Schwer, H. D., P. Lecine, S. Tiwari, J. E. Italiano, Jr., J. H. Hartwig, and R. A. Shivdasani. 2001. A lineage-restricted and divergent beta-tubulin isoform is essential for the biogenesis, structure and function of blood platelets. Curr. Biol. 11:579-586.
53. Seth, A., L. Robinson, D. M. Thompson, D. K. Watson, and T. S. Papas. 1993. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/ Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody. Oncogene 8:1783-1790.
54. Seth, A., and D. K. Watson. 2005. ETS transcription factors and their emerging roles in human cancer. Eur. J. Cancer. 41:2462-2478.
55. Shavit, J. A., H. Motohashi, K. Onodera, J. Akasaka, M. Yamamoto, and J. D. Engel. 1998. Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice. Genes Dev. 12:2164-2174.
56. Shivdasani, R. A., Y. Fujiwara, M. A. McDevitt, and S. H. Orkin. 1997. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 16:3965-3973.
57. Shivdasani, R. A., and S. H. Orkin. 1995. Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc. Natl. Acad. Sci. U. S. A. 92:8690-8694.
58. Spyropoulos, D. D., P. N. Pharr, K. R. Lavenburg, P. Jackers, T. S. Papas, M. Ogawa, and D. K. Watson. 2000. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol. Cell. Biol. 20:5643-5652.
59. Stankiewicz, M. J., and J. D. Crispino. 2009. ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells. Blood 113:3337-3347.
60. Starck, J., N. Cohet, C. Gonnet, S. Sarrazin, Z. Doubeikovskaia, A. Doubeikovski, A. Verger, M. Duterque-Coquillaud, and F. Morle. 2003. Functional cross-antagonism between transcription factors FLI-1 and EKLF. Mol. Cell. Biol. 23:1390-1402.
61. Szalai, G., A. C. LaRue, and D. K. Watson. 2006. Molecular mechanisms of megakaryopoiesis. Cell. Mol. Life Sci. 63:2460-2476.
62. Waga, K., Y. Nakamura, K. Maki, H. Arai, T. Yamagata, K. Sasaki, M. Kurokawa, H. Hirai, and K. Mitani. 2003. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells. Oncogene 22:59-68. (Pubitemid 36152884)
63. Wang, Q., T. Stacy, M. Binder, M. Marin-Padilla, A. H. Sharpe, and N. A. Speck. 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. U. S. A. 93:3444-3449.
64. Wang, X., J. D. Crispino, D. L. Letting, M. Nakazawa, M. Poncz, and G. A. Blobel. 2002. Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. EMBO J. 21:5225-5234.
65. Watson, D. K., L. Robinson, D. R. Hodge, I. Kola, T. S. Papas, and A. Seth. 1997. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements. Oncogene 14:213-221.
66. Watson, D. K., F. E. Smyth, D. M. Thompson, J. Q. Cheng, J. R. Testa, T. S. Papas, and A. Seth. 1992. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors. Cell Growth Differ. 3:705-713.
67. Yordy, J. S., R. Li, V. I. Sementchenko, H. Pei, R. C. Muise-Helmericks, and D. K. Watson. 2004. SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion. Oncogene 23:6654-6665.
68. Zhang, L., A. Eddy, Y.-T. Teng, M. Fritzler, M. Kluppel, F. Melet, and A. Bernstein. 1995. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Mol. Cell. Biol. 15:6961-6970.
69. Zhang, L., V. Lemarchandel, P. H. Romeo, Y. Ben-David, P. Greer, and A. Bernstein. 1993. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. Oncogene 8:1621-1630.
70. Zhang, X. K., O. Moussa, A. LaRue, S. Bradshaw, I. Molano, D. D. Spyropoulos, G. S. Gilkeson, and D. K. Watson. 2008. The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice. J. Immunol. 181:1644-1654.
71. Zheng, C., R. Yang, Z. Han, B. Zhou, L. Liang, and M. Lu. 2008. TPO-independent megakaryocytopoiesis. Crit. Rev. Oncol. Hematol. 65:212-222.